United States · FDA National Drug Code directory
Ranitidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53746-253_906b462d-e4a3-4f23-8d1b-2605476c40e8
- Product NDC
- 53746-253
- Form
- TABLET
- Composition / generic term
- Ranitidine
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091216
- Source listing expiry
- 20271231
Source-listed ingredients
- RANITIDINE HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (53746-253-01) · 53746-253-01
- 500 TABLET in 1 BOTTLE (53746-253-05) · 53746-253-05
- 1000 TABLET in 1 BOTTLE (53746-253-10) · 53746-253-10
- 180 TABLET in 1 BOTTLE (53746-253-18) · 53746-253-18
- 60 TABLET in 1 BOTTLE (53746-253-60) · 53746-253-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →